150 related articles for article (PubMed ID: 32042286)
1. A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma.
Bareille P; Tomkins S; Imber V; Tayob M; Dunn K; Mehta R; Khindri S
Allergy Asthma Clin Immunol; 2020; 16():11. PubMed ID: 32042286
[TBL] [Abstract][Full Text] [Related]
2. Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.
Allen A; Schenkenberger I; Trivedi R; Cole J; Hicks W; Gul N; Jacques L
Clin Respir J; 2013 Oct; 7(4):397-406. PubMed ID: 23578031
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
4. Randomized Trial of Once-Daily Fluticasone Furoate in Children with Inadequately Controlled Asthma.
Oliver AJ; Covar RA; Goldfrad CH; Klein RM; Pedersen SE; Sorkness CA; Tomkins SA; Villarán C; Grigg J
J Pediatr; 2016 Nov; 178():246-253.e2. PubMed ID: 27622699
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.
Meltzer EO; Tripathy I; Máspero JF; Wu W; Philpot E
Clin Drug Investig; 2009; 29(2):79-86. PubMed ID: 19133703
[TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized, double-blind, placebo-controlled, parallel-group study to evaluate the effects of a 1-year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well-controlled asthma.
Bareille P; Imber V; Crawford J; Majorek-Olechowska B; Karam-Absi Z; Stone S; Birk R
Pediatr Pulmonol; 2023 Dec; 58(12):3487-3497. PubMed ID: 37728224
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
Patel D; Ratner P; Clements D; Wu W; Faris M; Philpot E
Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
9. Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial.
Wolthers OD; Stone S; Bareille P; Tomkins S; Khindri S
Clin Ther; 2017 Jun; 39(6):1191-1199. PubMed ID: 28545804
[TBL] [Abstract][Full Text] [Related]
10. Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
O'Byrne PM; Jacques L; Goldfrad C; Kwon N; Perrio M; Yates LJ; Busse WW
Respir Res; 2016 Nov; 17(1):157. PubMed ID: 27881132
[TBL] [Abstract][Full Text] [Related]
11. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
Bernstein D; Andersen L; Forth R; Jacques L; Yates L
J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
[TBL] [Abstract][Full Text] [Related]
12. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial.
Oliver A; Allen A; VanBuren S; Hamilton M; Tombs L; Kempsford R; Qaqundah P
Clin Pharmacol Drug Dev; 2014 Mar; 3(2):144-50. PubMed ID: 27128459
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects.
Chen X; Zheng X; Jiang J; Hu P; Wu K; Zhuang L; Liu L; Du X; Kempsford R; Allen A
Pharmacotherapy; 2015 Jun; 35(6):586-99. PubMed ID: 26059225
[TBL] [Abstract][Full Text] [Related]
15. Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.
Bleecker ER; Lötvall J; O'Byrne PM; Woodcock A; Busse WW; Kerwin EM; Forth R; Medley HV; Nunn C; Jacques L; Bateman ED
J Allergy Clin Immunol Pract; 2014; 2(5):553-61. PubMed ID: 25213048
[TBL] [Abstract][Full Text] [Related]
16. The relationship between fluticasone furoate systemic exposure and cortisol suppression.
Allen A
Clin Pharmacokinet; 2013 Oct; 52(10):885-96. PubMed ID: 23719680
[TBL] [Abstract][Full Text] [Related]
17. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
Kosoglou T; Cutler DL; Staudinger H; Herron JM
Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A; Jacques L; Frith L
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.
Oliver A; VanBuren S; Allen A; Hamilton M; Tombs L; Inamdar A; Kempsford R
Clin Ther; 2014 Jun; 36(6):928-939.e1. PubMed ID: 24793536
[TBL] [Abstract][Full Text] [Related]
20. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
Bleecker ER; Bateman ED; Busse WW; Woodcock A; Frith L; House KW; Jacques L; Davis AM; Haumann B; Lötvall J
Ann Allergy Asthma Immunol; 2012 Nov; 109(5):353-358.e4. PubMed ID: 23062392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
